1285 related articles for article (PubMed ID: 12210859)
1. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
[TBL] [Abstract][Full Text] [Related]
2. Application of the International Cooperative Ataxia Scale rating in multiple system atrophy.
Tison F; Yekhlef F; Balestre E; Chrysostome V; Quinn N; Wenning GK; Poewe W
Mov Disord; 2002 Nov; 17(6):1248-54. PubMed ID: 12465064
[TBL] [Abstract][Full Text] [Related]
3. The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group.
LeWitt P; Oakes D; Cui L
Mov Disord; 1997 Mar; 12(2):183-9. PubMed ID: 9087976
[TBL] [Abstract][Full Text] [Related]
4. Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination section.
Stebbins GT; Goetz CG
Mov Disord; 1998 Jul; 13(4):633-6. PubMed ID: 9686766
[TBL] [Abstract][Full Text] [Related]
5. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
Saiki S; Hirose G; Sakai K; Kataoka S; Hori A; Saiki M; Kaito M; Higashi K; Taki S; Kakeshita K; Fujino S; Miaki M
J Neurol Sci; 2004 May; 220(1-2):105-11. PubMed ID: 15140615
[TBL] [Abstract][Full Text] [Related]
6. Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG).
Geser F; Wenning GK; Seppi K; Stampfer-Kountchev M; Scherfler C; Sawires M; Frick C; Ndayisaba JP; Ulmer H; Pellecchia MT; Barone P; Kim HT; Hooker J; Quinn NP; Cardozo A; Tolosa E; Abele M; Klockgether T; Østergaard K; Dupont E; Schimke N; Eggert KM; Oertel W; Djaldetti R; Poewe W;
Mov Disord; 2006 Feb; 21(2):179-86. PubMed ID: 16161136
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS).
Wenning GK; Tison F; Seppi K; Sampaio C; Diem A; Yekhlef F; Ghorayeb I; Ory F; Galitzky M; Scaravilli T; Bozi M; Colosimo C; Gilman S; Shults CW; Quinn NP; Rascol O; Poewe W;
Mov Disord; 2004 Dec; 19(12):1391-402. PubMed ID: 15452868
[TBL] [Abstract][Full Text] [Related]
8. Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group.
Martínez-Martín P; Gil-Nagel A; Gracia LM; Gómez JB; Martínez-Sarriés J; Bermejo F
Mov Disord; 1994 Jan; 9(1):76-83. PubMed ID: 8139608
[TBL] [Abstract][Full Text] [Related]
9. Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial.
Siderowf A; McDermott M; Kieburtz K; Blindauer K; Plumb S; Shoulson I;
Mov Disord; 2002 Jul; 17(4):758-63. PubMed ID: 12210871
[TBL] [Abstract][Full Text] [Related]
10. Psychometric properties of the Unified Parkinson's Disease Rating Scale and of the Short Parkinson's Evaluation Scale.
Martignoni E; Franchignoni F; Pasetti C; Ferriero G; Picco D
Neurol Sci; 2003 Oct; 24(3):190-1. PubMed ID: 14598081
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of quality of life in multiple system atrophy and Parkinson's disease].
Torny F; Lacoste M; Videaud H; Chouly M; Parveau MC; Couratier P
Rev Neurol (Paris); 2009 Nov; 165(11):911-5. PubMed ID: 19324385
[TBL] [Abstract][Full Text] [Related]
12. Diagnosing multiple system atrophy with greater accuracy: combined analysis of the clonidine-growth hormone test and external anal sphincter electromyography.
Lee EA; Kim BJ; Lee WY
Mov Disord; 2002 Nov; 17(6):1242-7. PubMed ID: 12465063
[TBL] [Abstract][Full Text] [Related]
13. Rating impairment and disability in Parkinson's disease: evaluation of the Unified Parkinson's Disease Rating Scale.
van Hilten JJ; van der Zwan AD; Zwinderman AH; Roos RA
Mov Disord; 1994 Jan; 9(1):84-8. PubMed ID: 8139609
[TBL] [Abstract][Full Text] [Related]
14. Metric attributes of the unified Parkinson's disease rating scale 3.0 battery: part II, construct and content validity.
Forjaz MJ; Martinez-Martin P
Mov Disord; 2006 Nov; 21(11):1892-8. PubMed ID: 16958134
[TBL] [Abstract][Full Text] [Related]
15. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
[TBL] [Abstract][Full Text] [Related]
16. Red flags for multiple system atrophy.
Köllensperger M; Geser F; Seppi K; Stampfer-Kountchev M; Sawires M; Scherfler C; Boesch S; Mueller J; Koukouni V; Quinn N; Pellecchia MT; Barone P; Schimke N; Dodel R; Oertel W; Dupont E; Østergaard K; Daniels C; Deuschl G; Gurevich T; Giladi N; Coelho M; Sampaio C; Nilsson C; Widner H; Sorbo FD; Albanese A; Cardozo A; Tolosa E; Abele M; Klockgether T; Kamm C; Gasser T; Djaldetti R; Colosimo C; Meco G; Schrag A; Poewe W; Wenning GK;
Mov Disord; 2008 Jun; 23(8):1093-9. PubMed ID: 18442131
[TBL] [Abstract][Full Text] [Related]
17. Factors predicting response to dopaminergic treatment for resting tremor of Parkinson's disease.
Sung YH; Chung SJ; Kim SR; Lee MC
Mov Disord; 2008 Jan; 23(1):137-40. PubMed ID: 17987649
[TBL] [Abstract][Full Text] [Related]
18. Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.
Köllensperger M; Geser F; Ndayisaba JP; Boesch S; Seppi K; Ostergaard K; Dupont E; Cardozo A; Tolosa E; Abele M; Klockgether T; Yekhlef F; Tison F; Daniels C; Deuschl G; Coelho M; Sampaio C; Bozi M; Quinn N; Schrag A; Mathias CJ; Fowler C; Nilsson CF; Widner H; Schimke N; Oertel W; Del Sorbo F; Albanese A; Pellecchia MT; Barone P; Djaldetti R; Colosimo C; Meco G; Gonzalez-Mandly A; Berciano J; Gurevich T; Giladi N; Galitzky M; Rascol O; Kamm C; Gasser T; Siebert U; Poewe W; Wenning GK;
Mov Disord; 2010 Nov; 25(15):2604-12. PubMed ID: 20922810
[TBL] [Abstract][Full Text] [Related]
19. Reliability of patient completion of the historical section of the Unified Parkinson's Disease Rating Scale.
Louis ED; Lynch T; Marder K; Fahn S
Mov Disord; 1996 Mar; 11(2):185-92. PubMed ID: 8684390
[TBL] [Abstract][Full Text] [Related]
20. [Utility of the study of the vegetative nervous system in the differential diagnosis between Parkinson's disease and multiple system atrophy].
Rouco I; Gómez JC; Lezcano E; Aniel-Quiroga MA; Velasco F; Barcena J; Pérez Bas M; Hurtado P; Cruz Lachén M; Zarranz JJ
Neurologia; 2006 Apr; 21(3):119-23. PubMed ID: 16575624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
